Task A68: Screening Vaccine (and Other Biologics) Platform Technologies using Coronavirus Mouse Immunogenicity as a Model System

NIH Pandemic-Era Grants

Pandemic Era Grants

2024

↗ Live URL (may be dead)

Document text

Principal Investigator: RALPH  BARIC
Organization: UNIV OF NORTH CAROLINA CHAPEL HILL
Fiscal Year: 2024
Award: $563,541
Funding agency: National Institute of Allergy and Infectious Diseases

This contract provides for the development of new and refinement of existing models of infectious diseases and may include evaluation of candidate countermeasures.

Terms: <Biologic Models><Biological Agent><Biological Models><Biological Products><Contracting Opportunities><Contracts><Coronaviridae><Coronavirus><Development><Evaluation><Mice><Mice Mammals><Model System><Murine><Mus><biologics><biopharmaceutical><biotherapeutic agent><corona virus><coronavirus vaccine><develop a vaccine><develop vaccines><development of a vaccine><developmental><evaluate vaccines><immunogenicity><infectious disease model><technology platform><technology system><vaccine against coronavirus><vaccine candidate against coronavirus><vaccine development><vaccine evaluation><vaccine screening><vaccine testing>